Discover our flagship diagnostic, monitoring, and urology consumables. Manufactured under strict ISO 13485 quality standards within monitored Class 10,000 cleanroom environments, each unit delivers absolute signal stability, bio-compatibility, and operational reliability.
In the modern clinical environment, cardiac monitoring and physiological fluid management demand absolute physical precision and bio-electrochemical consistency. As a premier OEM/ODM ECG Electrodes Manufacturer & Supplier, our research and contract manufacturing framework integrates advanced materials science with state-of-the-art automated assembly lines. Electrocardiogram (ECG) monitoring relies on stable interface kinetics between the patient's epidermis and the diagnostic acquisition equipment. Any artifact, baseline wander, or impedance variance can lead to misinterpretation of cardiac rhythms in intensive care units (ICUs) and operating theatres.
To overcome signal degradation, high-performance OEM ECG electrodes utilize ultra-pure Silver/Silver Chloride (Ag/AgCl) sensor substrates coupled with conductive, non-irritating hydrogels. The hydrogel formulation serves a dual purpose: maintaining consistent low impedance (under 300 ohms at 10 Hz) while preserving skin moisture balance over prolonged monitoring sessions. Concurrently, our medical disposable division applies this same level of bio-compatible polymer engineering to urological devices, such as 100% medical-grade silicone Foley catheters and ergonomic tube stabilization systems.
Micro-calibrated silver/silver chloride sensors providing instantaneous signal acquisition, zero baseline drift, and minimum cardiac trace artifact in stress and Holter testing.
Hypoallergenic, high-tack conductive hydrogels engineered for extended wear (up to 7 days) without causing chemical skin erosion or contact dermatitis.
Translucent, 100% liquid silicone urinary catheters featuring smooth side eyes and symmetrical inflatable balloons to minimize urethral trauma and mucosal irritation.
To support hospital procurement tenders and B2B private label customization, the following matrix outlines our standard engineering tolerances and material grades available for contract manufacturing:
| Product Category | Core Substrate Material | Biocompatibility Standard | Shelf Life / Sterilization | Primary Application Segment |
|---|---|---|---|---|
| Diagnostic ECG Electrodes | Ag/AgCl Sensor, PE Foam / Non-Woven | ISO 10993-5 (Cytotoxicity), ISO 10993-10 | 24 Months / Gamma or ETO | Resting ECG, Stress Test, Emergency Care |
| Monitoring ECG Electrodes | Solid / Wet Hydrogel, Breathable Tape | ISO 10993 Non-Irritating, Latex-Free | 36 Months / ETO Sterilized | Long-term ICU Monitoring, Holter Telemetry |
| Pediatric & MRI Electrodes | Radiolucent Carbon Element, Conductive Gel | ISO 10993 Pediatric Safe Grade | 24 Months / ETO Sterilized | X-Ray, MRI Suites, Neonatal Intensive Care |
| Silicone Foley Catheters | 100% Liquid Medical-Grade Silicone | ISO 10993-1, USP Class VI Certified | 5 Years / In-House Validated ETO | Urological Drainage, Intraoperative Care |
| Catheter Securement Stickers | Breathable Non-Woven fabric with PSA Adhesive | Skin-friendly Hypoallergenic Acrylic | 3 Years / ETO Clean Pack | Preventing Catheter Traction & Skin Tears |
The global market for electro-cardiology consumables and single-use urological devices is undergoing a structural shift. Hospital procurement departments, ministry health tenders, and international medical brand owners are moving rapidly beyond transactional price sourcing. Sourcing strategies in 2026 and beyond are heavily focused on three core pillars: Regulatory Resilience, Supply Chain Traceability, and Material Sustainability.
First, regulatory scrutiny has escalated worldwide. With the full implementation of the European Union Medical Device Regulation (EU MDR 2017/745) and strict compliance demands from the US FDA, medical buyers can no longer source from unverified second-tier vendors. Distributors require comprehensive Technical Master Files (TMF), ISO 13485 certified quality management documentation, and validated shelf-life data. Partnering with an established CDMO/OEM vendor guarantees that every batch is backed by full resin-to-pouch traceability.
Second, wearable continuous monitoring and telemetry are expanding from hospital ICUs to outpatient and home-care settings. Demand for high-tack, water-resistant ECG electrodes compatible with wireless transmitters has surged by over 18% annually. Concurrently, hospital infection control boards are enforcing strict protocols to eradicate Catheter-Associated Urinary Tract Infections (CAUTI). This clinical push has elevated the procurement ratio of 100% silicone Foley catheters—which possess superior biostability and lower encrustation rates compared to traditional latex alternatives—alongside specialized catheter stabilization devices that prevent mechanical motion artifacts and tissue strain.
Transition away from latex and PVC toward medical-grade silicone to eliminate patient allergic reactions, diminish bacterial adhesion, and meet environmental disposal guidelines.
Mandatory UDI (Unique Device Identification) barcoding, rigorous clinical evaluation reports (CER), and lot-level ETO residual verification for seamless global tender entry.
Surging adoption of carbon-backed, radiolucent ECG electrodes designed for seamless artifact-free imaging during surgical procedures and CT scans.
As medical technology evolves toward non-invasive diagnostics and minimally invasive patient care, manufacturing processes must continuously innovate. In the field of cardiac telemetry, future electrode designs are incorporating advanced printed electronics, dry-sensor hybrid polymers, and micro-fluidic hydrogels. These innovations allow continuous 30-day arrhythmia monitoring without hydrogel desiccation or severe skin reaction.
Simultaneously, catheter engineering is witnessing breakthroughs in surface modification technologies. Hydrophilic coatings that activate upon contact with water drastically reduce friction during insertion, enhancing patient comfort and reducing mucosal trauma. Furthermore, three-way silicone catheters with integrated irrigation channels are increasingly specified for post-operative prostatectomy care, where maintaining clear fluid evacuation and preventing clot formation is vital.
As a leading CDMO partner, our facility invests heavily in high-speed, automated injection molding, optical vision inspection systems, and automated pouch sealing. By replacing manual handling with robotic precision, we maintain ultra-low defect rates (below 10 PPM) across millions of produced units, ensuring that brand owners receive identical, pristine products in every shipment.
Founded in 1994 in Gujarat, India, our enterprise (Angiplast Private Limited) has built a solid international reputation over 30+ years as an integrated manufacturer and exporter of single-use medical devices. Operating from an expansive, state-of-the-art industrial park, our production plant is engineered specifically to meet stringent international standards required by healthcare authorities in over 52 countries.
Our operational superiority rests on full vertical integration. Unlike assemblers who source components from unverified third-party machine shops, we manage every critical phase of device fabrication under one roof:
Partner with a certified, globally trusted OEM/ODM manufacturer. Contact our engineering and export desk today to request sample packs, detailed technical specification sheets, or a competitive tender quotation.
Get a Quote
